Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
NRG1 fusion in a French cohort of invasive mucinous lung adenocarcinoma.
Duruisseaux M, McLeer-Florin A, Antoine M, Alavizadeh S, Poulot V, Lacave R, Rabbe N, Cadranel J, Wislez M. Duruisseaux M, et al. Cancer Med. 2016 Dec;5(12):3579-3585. doi: 10.1002/cam4.838. Epub 2016 Oct 21. Cancer Med. 2016. PMID: 27770508 Free PMC article.
SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer.
Borghaei H, de Marinis F, Dumoulin D, Reynolds C, Theelen WSME, Percent I, Gutierrez Calderon V, Johnson ML, Madroszyk-Flandin A, Garon EB, He K, Planchard D, Reck M, Popat S, Herbst RS, Leal TA, Shazer RL, Yan X, Harrigan R, Peters S; SAPPHIRE Investigators. Borghaei H, et al. Ann Oncol. 2024 Jan;35(1):66-76. doi: 10.1016/j.annonc.2023.10.004. Epub 2023 Oct 20. Ann Oncol. 2024. PMID: 37866811 Clinical Trial.
Chemotherapy effectiveness after first-line gefitinib treatment for advanced lepidic predominant adenocarcinoma (formerly advanced bronchioloalveolar carcinoma): exploratory analysis of the IFCT-0401 trial.
Duruisseaux M, Baudrin L, Quoix E, Wislez M, Moro-Sibilot D, Coëtmeur D, Monnet I, Mourlanette P, Morère JF, Soria JC, Westeel V, Morin F, Cadranel J. Duruisseaux M, et al. J Thorac Oncol. 2012 Sep;7(9):1423-31. doi: 10.1097/JTO.0b013e31825ab897. J Thorac Oncol. 2012. PMID: 22767177 Free article. Clinical Trial.
[Pulmonary sarcomatoid carcinoma].
Vieira T, Duruisseaux M, Ruppert AM, Cadranel J, Antoine M, Wislez M. Vieira T, et al. Among authors: duruisseaux m. Bull Cancer. 2012 Oct;99(10):995-1001. doi: 10.1684/bdc.2012.1619. Bull Cancer. 2012. PMID: 22889810 Review. French.
Clinical and molecular features in patients with advanced non-small-cell lung carcinoma refractory to first-line platinum-based chemotherapy.
Giroux Leprieur E, Antoine M, Vieira T, Duruisseaux M, Poulot V, Rabbe N, Belmont L, Gounant V, Lavolé A, Milleron B, Lacave R, Cadranel J, Wislez M. Giroux Leprieur E, et al. Among authors: duruisseaux m. Lung Cancer. 2013 Feb;79(2):167-72. doi: 10.1016/j.lungcan.2012.10.010. Epub 2012 Nov 13. Lung Cancer. 2013. PMID: 23153658
83 results